Nichol Ochsner
Investor Relations Contact chez ZEVRA THERAPEUTICS, INC.
Profil
Nichol Ochsner is currently the VP-Investor Relations & Corporate Communications at Zevra Therapeutics, Inc. and is a member of the National Investor Relations Institute.
Previously, he worked as the Director-Corporate Communications at Medarex, Inc., Executive Director-IR & Corporate Communications at Old API Wind-down Ltd., VP-Investor Relations & Corporate Communications at TherapeuticsMD, Inc., and EVP-Investor Relations & Corporate Communications at Statera Biopharma, Inc. He obtained an undergraduate degree from West Virginia University.
Postes actifs de Nichol Ochsner
| Sociétés | Poste | Début |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Investor Relations Contact | 09/08/2022 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Anciens postes connus de Nichol Ochsner
| Sociétés | Poste | Fin |
|---|---|---|
| OLD API WIND-DOWN LTD. | Investor Relations Contact | 01/05/2018 |
| STATERA BIOPHARMA, INC. | Investor Relations Contact | - |
| THERAPEUTICSMD, INC. | Investor Relations Contact | - |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Public Communications Contact | - |
Formation de Nichol Ochsner
| West Virginia University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| THERAPEUTICSMD, INC. | Health Technology |
| STATERA BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Inc. engages in the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the following geographical segments: United States and Canada. The company is founded on December 2, 2015, and is headquartered in Mississauga, Canada. | Health Technology |
